| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in immunotoxin engineering: precision therapeutic strategies in modern oncology
|
Oghalaie, Akbar
|
|
|
41 |
10 |
|
artikel
|
| 2 |
Comment on “gemcitabine, PI3kinase-Akt pathway inhibition and radiation in human glioma cell lines” by M.S. Elnaggar et al.1
|
Balaji, M. B.
|
|
|
41 |
10 |
|
artikel
|
| 3 |
Comment on “2-methoxyestradiol sensitizes tamoxifen-resistant MCF-7 breast cancer cells via downregulating HIF-1α”
|
Chellapandian, Hethesh
|
|
|
41 |
10 |
|
artikel
|
| 4 |
Current diagnostic and quantitative techniques in the field of lymphedema management: a critical review
|
Vargo, Mary
|
|
|
41 |
10 |
|
artikel
|
| 5 |
How mitochondrial dynamics imbalance affects the progression of breast cancer:a mini review
|
Kuang, Jingwen
|
|
|
41 |
10 |
|
artikel
|
| 6 |
Incidence of lymphedema related to various cancers
|
Letellier, Marie-Eve
|
|
|
41 |
10 |
|
artikel
|
| 7 |
Letter to the editor: comment on “Chitosan-loaded piperlongumine nanoparticles and kaempferol enhance the anti-cancer action of doxorubicin in targeting of Ehrlich solid adenocarcinoma: in vivo and in silico modeling study”
|
Gonemo, Adane Desta
|
|
|
41 |
10 |
|
artikel
|
| 8 |
Letter to the editor: comment on “Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment”
|
Santhoshkumar, Murali
|
|
|
41 |
10 |
|
artikel
|
| 9 |
Letter to the editor for the article “How mitochondrial dynamics imbalance affects the progression of breast cancer: a mini review”
|
Zhang, Yu
|
|
|
41 |
10 |
|
artikel
|
| 10 |
Lipid metabolism reprogramming in renal cell carcinomas
|
Abduljabbar, Mustafa Khalid
|
|
|
41 |
10 |
|
artikel
|
| 11 |
The role of IL-22 in cancer
|
Hunzeker, Zachary E.
|
|
|
41 |
10 |
|
artikel
|
| 12 |
The Sirt1/Nrf2 pathway is a key factor for drug therapy in chemotherapy-induced cardiotoxicity: a Mini-Review
|
Mohammad, Suleiman Ibrahim Shelash
|
|
|
41 |
10 |
|
artikel
|
| 13 |
The treatment landscape of triple-negative breast cancer
|
Hu, Yi
|
|
|
41 |
10 |
|
artikel
|
| 14 |
Turning the tide: pembrolizumab’s triumph in adjuvant RCC therapy
|
Attieh, Fouad
|
|
|
41 |
10 |
|
artikel
|
Tijdschrift beschrijving